AU663064B2 - Hepatitis C virus antibody - Google Patents

Hepatitis C virus antibody

Info

Publication number
AU663064B2
AU663064B2 AU89457/91A AU8945791A AU663064B2 AU 663064 B2 AU663064 B2 AU 663064B2 AU 89457/91 A AU89457/91 A AU 89457/91A AU 8945791 A AU8945791 A AU 8945791A AU 663064 B2 AU663064 B2 AU 663064B2
Authority
AU
Australia
Prior art keywords
antibody
plasma
virus
hepatitis
hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU89457/91A
Other languages
English (en)
Other versions
AU8945791A (en
Inventor
Warren Hugh Bryce
Richard R. Lesniewski
Mahlon F. Miller
David A Peterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU8945791A publication Critical patent/AU8945791A/en
Application granted granted Critical
Publication of AU663064B2 publication Critical patent/AU663064B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU89457/91A 1990-10-12 1991-10-09 Hepatitis C virus antibody Expired - Fee Related AU663064B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59681190A 1990-10-12 1990-10-12
US596811 1990-10-12
PCT/US1991/007571 WO1992007001A1 (en) 1990-10-12 1991-10-09 Hepatitis c virus antibody

Publications (2)

Publication Number Publication Date
AU8945791A AU8945791A (en) 1992-05-20
AU663064B2 true AU663064B2 (en) 1995-09-28

Family

ID=24388816

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89457/91A Expired - Fee Related AU663064B2 (en) 1990-10-12 1991-10-09 Hepatitis C virus antibody

Country Status (7)

Country Link
EP (1) EP0552297A1 (enrdf_load_stackoverflow)
JP (1) JPH06502075A (enrdf_load_stackoverflow)
KR (1) KR930702506A (enrdf_load_stackoverflow)
AU (1) AU663064B2 (enrdf_load_stackoverflow)
CA (1) CA2093919A1 (enrdf_load_stackoverflow)
TW (1) TW216797B (enrdf_load_stackoverflow)
WO (1) WO1992007001A1 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69131046T2 (de) * 1990-11-07 1999-10-21 Abbott Laboratories, Abbott Park Monoklonale antikörper gegen den hepatitis c-virus und verfahren diese zu benutzen
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
ATE534666T1 (de) 2003-04-01 2011-12-15 Inst Nat Sante Rech Med Antikörper gegen den hepatitis c-virus e1e2 komplex und pharmazeutische zusammensetzungen
DK2125889T3 (da) 2007-02-21 2014-04-14 Univ Massachusetts Humane antistoffer mod hepatitis c-virus (hcv) og anvendelser deraf

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318216A1 (en) * 1987-11-18 1989-05-31 Chiron Corporation NANBV diagnostics and vaccines
AU632271B2 (en) * 1988-03-30 1992-12-24 Abbott Laboratories Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver
AU640920B2 (en) * 1989-03-17 1993-09-09 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics and vaccines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318216A1 (en) * 1987-11-18 1989-05-31 Chiron Corporation NANBV diagnostics and vaccines
AU632271B2 (en) * 1988-03-30 1992-12-24 Abbott Laboratories Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver
AU640920B2 (en) * 1989-03-17 1993-09-09 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics and vaccines

Also Published As

Publication number Publication date
KR930702506A (ko) 1993-09-09
JPH06502075A (ja) 1994-03-10
EP0552297A1 (en) 1993-07-28
CA2093919A1 (en) 1992-04-13
EP0552297A4 (enrdf_load_stackoverflow) 1994-02-09
TW216797B (enrdf_load_stackoverflow) 1993-12-01
WO1992007001A1 (en) 1992-04-30
AU8945791A (en) 1992-05-20

Similar Documents

Publication Publication Date Title
DE69131488T2 (de) Kombinationen der Hepatitis-C-Virus (HCV) Antigene zur Verwendung in Immuntests für Anti-HCV-Antikörper
Mellors et al. Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus.
Anderson et al. Diagnosis of human parvovirus infection by dot‐blot hybridization using cloned viral DNA
JP3490085B2 (ja) 構造エピトープを有する抗原を用いる抗ｈｃｖ抗体のイムノアッセイ
US5110738A (en) Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
US3951937A (en) Large scale purification of hepatitis type B antigen using polyethylene glycol
CA1194792A (en) Non-a, non-b hepatitis-associated monoclonal antibody and diagnostic reagent
Dreesman et al. Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats
KR930001278B1 (ko) B형 간염 표면 항원(HBsAg)에 대한 모노클로널 항체의 제조방법
CA2252466C (en) Hepatitis b monoclonal antibodies
Hirashima et al. Regulatory role of IgE-binding factors from rat T lymphocytes. IV. Formation of IgE-binding factors in rats treated with complete Freund's adjuvant.
JPH08242849A (ja) 限外濾過によるタンパク質溶液からのウイルスの除去
JPH0250426B2 (enrdf_load_stackoverflow)
AU663064B2 (en) Hepatitis C virus antibody
EP0186360A2 (en) Methods for preparation of highly purified, gamma globulins free of hepatitis-B-virus infectivity
KR930000186B1 (ko) 비-a, 비-b형 간염 감염된 간에 대한 모노클로날 항체
EP0068465B1 (en) Non-a, non-b hepatitis-associated antibody conjugate, the use thereof and detection reagent
Ma et al. Multiple sclerosis serum and cerebrospinal fluid immunoglobulin binding to Fc receptors of oligodendrocytes
US4132767A (en) Preparation of α-L antibody, purification of α-L antigen and reagent for detection of α-L antibody and α-L antigen
US5419906A (en) Preparation of human immunoglobulin free of hepatitis C
SANTOS et al. Trypanosoma cruzi: binding of parasite antigens to mammalian cell membranes
EP0308242B1 (en) Agglutination assay
Buck et al. A rapid method for the large scale preparation of bovine leukemia virus antigen
US5162224A (en) Monoclonal antibodies specific for b cells and htlv-i transformed t cells
CA1335355C (en) Anti-cpbii monoclonal antibody